Category Neurology
Press Release
GB Sciences Signs Licensing Deal With EndoPure Life Sciences for 5% Gross Sales Royalty & Sponsorship of First-in-Human Trial for Their Cannabinoid-Based Parkinson’s Drug
As a part of their Exclusive Licensing Deal, EndoPure Life Sciences will finance and sponsor first-in-human clinical trials, which help to advance GB Sciences’ cannabinoid-based products globally. Read More
Press Release
GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences
GB Sciences’ Licensing Deal with Endopure Life Sciences will also include Rights to Develop and Market GB Sciences’ Cannabinoid-based Treatments for a Suite of Neurological Disorders Read More
Press Release
The Siegel Rare Neuroimmune Association Creates First-Ever Online Micro-Course for People With Rare Neuroimmune Disorders
The online learning program reflects organization’s dedication to empowering individuals and families affected by these conditions with knowledge and support Read More
Press Release
Neuroscience and Quantum Researcher Ali Karakus Aims to Slow Aging of Brain and Facial Cells Using Principles of Quantum Entanglement and Space-Time Dilation
Ali Karakus' Innovative Project Aims to Slow Aging of Brain and Facial Cells, Leading to the Foundation of a Private Deep Tech Institute in Istanbul Read More
Press Release
All-In Nutritionals and Autism Today’s CEOs Create Joint Company, Neuro Nutritionals, to Support Autism and Neurodiverse Community
Lindsey Duncan, CN, ND, and founder of All-In Nutritionals, joins forces with Karen Simmons, founder and CEO of Autism Today, to co-found Neuro Nutritionals, LLC, a new company dedicated to providing targeted solutions, education, and supplements that support individuals on the spectrum. Read More
Press Release
Mentavi Health Partnering with Colleges, Universities to Help Students with Mental Health Services
The leader in mental health assessments is helping institutions that have limited resources and are outsourcing mental health assessments for ADHD, anxiety and depression to off-campus providers. Read More
Press Release
Ischemix, Inc. Completes Successful Phase 1 Trial of Novel Compound to Treat Traumatic Brain Injury (TBI); Preparing for Conduct of Phase 2 Trial
CMX-2043, a novel, proprietary cytoprotective drug candidate, demonstrated excellent safety and tolerability in a Phase 1 single ascending and multiple ascending dose (SAD-MAD) clinical trial. CMX-2043 has previously demonstrated safety and efficacy in extensive preclinical pharmacology, toxicology and TBI translational studies. CMX-2043 will be Phase 2-ready by the first quarter of 2024. Read More
Press Release
An Independent Study Comparing Blink Reflex Detection Device EyeStat to Standard Lab Techniques Concludes That the Device Provides Reliable and Accurate Measures
The research opens the doors for promising applications that can help people with neurological diseases such as Parkinson's. Read More
Press Release
Neurocentria Announces Dr. Thomas Südhof to Join the Scientific Advisory Board
The appointment further strengthens the company's scientific resources, including in neuronal function and synaptic transmission, which are central to Neurocentria's approach for developing novel therapies for neurodegenerative and neuropsychiatric disorders. Read More
Press Release
31 ADHD Stories in 31 Days with Award-Winning Journalist and TV/Radio Personality Lindsay Guentzel and ADHD Online
Guentzel and ADHD Online partner to publish a podcast episode every day during October, providing information and support while breaking down stigmas about ADHD and mental health. Read More
Press Release
Cortechs.ai Awarded Million Dollar NIH Grant for Early Diagnosis of Alzheimer's Disease Using Advanced Diffusion MRI Technique
The National Institute of Health awards Cortechs.ai a multimillion grant to quantify microstructural changes in Alzheimer's Disease using Restriction Spectrum Imaging. Read More
Press Release
